Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial.
Ohguri T, Harima Y, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. Ohguri T, et al. Among authors: harima y. Int J Hyperthermia. 2018 Jun;34(4):461-468. doi: 10.1080/02656736.2017.1352105. Epub 2017 Jul 19. Int J Hyperthermia. 2018. PMID: 28679349 Free article. Clinical Trial.
Clinical value of serum biomarkers, squamous cell carcinoma antigen and apolipoprotein C-II in follow-up of patients with locally advanced cervical squamous cell carcinoma treated with radiation: A multicenter prospective cohort study.
Harima Y, Ariga T, Kaneyasu Y, Ikushima H, Tokumaru S, Shimamoto S, Takahashi T, Ii N, Tsujino K, Saito AI, Ushijima H, Toita T, Ohno T. Harima Y, et al. PLoS One. 2021 Nov 2;16(11):e0259235. doi: 10.1371/journal.pone.0259235. eCollection 2021. PLoS One. 2021. PMID: 34727105 Free PMC article.
Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study.
Ariga T, Toita T, Kato S, Kazumoto T, Kubozono M, Tokumaru S, Eto H, Nishimura T, Niibe Y, Nakata K, Kaneyasu Y, Nonoshita T, Uno T, Ohno T, Iwata H, Harima Y, Wada H, Yoshida K, Gomi H, Numasaki H, Teshima T, Yamada S, Nakano T. Ariga T, et al. Among authors: harima y. J Radiat Res. 2015 Sep;56(5):841-8. doi: 10.1093/jrr/rrv036. Epub 2015 Jun 24. J Radiat Res. 2015. PMID: 26109680 Free PMC article.
A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.
Kaneyasu Y, Fujiwara H, Nishimura T, Sakurai H, Kazumoto T, Ikushima H, Uno T, Tokumaru S, Harima Y, Gomi H, Toita T, Kita M, Noda SE, Takahashi T, Kato S, Ohkawa A, Tozawa-Ono A, Ushijima H, Hasumi Y, Hirashima Y, Niibe Y, Nakagawa T, Akita T, Tanaka J, Ohno T; Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG). Kaneyasu Y, et al. Among authors: harima y. J Radiat Res. 2021 Mar 10;62(2):269-284. doi: 10.1093/jrr/rraa107. J Radiat Res. 2021. PMID: 33415337 Free PMC article.
Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients.
Ohno T, Wakatsuki M, Toita T, Kaneyasu Y, Yoshida K, Kato S, Ii N, Tokumaru S, Ikushima H, Uno T, Noda SE, Kazumoto T, Harima Y; The Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG). Ohno T, et al. Among authors: harima y. J Radiat Res. 2017 May 1;58(3):341-350. doi: 10.1093/jrr/rrw109. J Radiat Res. 2017. PMID: 27837120 Free PMC article.
113 results